leisure time -WSS

leisure time

author：comprehensive 2025-09-07 00:17:32 - browse：76

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The pink breast cancer awareness ribbon needs a redesign

WSS

A rare thyroid diagnosis led to unexpected, all

The pink breast cancer awareness ribbon needs a redesign

How to fix cancer clinical trials' diversity problem

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Eli Lilly to pay $200M for Beam’s stake in gene

Testing for cancer recurrence creates a new limbo for patients

hotspot

leisure time

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Amazon on where the company's health care bets are headed next

Trump demands the U.S. pay no more for drugs than other countries … again

How generative AI is inspiring dreams of a health data revolution

Moonlake's readout produced a cash windfall. Risks remain

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Supreme Court strikes down use of affirmative action

Medtronic CEO on promising devices for diabetes, hypertension

Duchenne breakthrough therapy leaves behind pioneering families

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

knowledge

The pink breast cancer awareness ribbon needs a redesign

The 10 drugs up first for Medicare price negotiation

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Amazon on where the company's health care bets are headed next

Readout Newsletter: What happened with Sarepta's Duchenne data

Humana sues Biden admin over Medicare Advantage audit rule

explore

explore

leisure time

leisure time